Shares of blood products company Haemonetics (NYSE:HAE). fell 2.1% in the morning session after Citigroup downgraded the stock to "Neutral" from "Buy." The action came from analyst Joanne Wuensch.

Deucrictibant shows rapid symptom relief and strong safety profile in RAPIDe-3 study Pharvaris has announced positive topline data from its RAPIDe-3 pivotal phase 3 study, confirming the potential of ...

Haemonetics (HAE) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.12 per share a year ago. These figures ...

EMBED <iframe src="https://archive.org/embed/sid-meiers-civilization-ii-64-bit-compatible" width="560" height="384" frameborder="0" webkitallowfullscreen="true ...

Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...

A new survey reveals that nearly 80% of ITAM and SAM professionals are moving away from Oracle Java, citing cost hikes, audit risks, and licensing confusion as key drivers. Nearly 8 in 10 ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Here are the most important concepts developers must know when they size Java arrays and deal ...

Actress Shin Hae Sun has joined a new agency! On April 30, Management Siseon announced it had signed an exclusive contract with Shin Hae Sun, stating, “Shin Hae Sun is an actress with strong acting ...

Writing from India, Ankit loves anything remotely fictional. He's been watching anime for years now, collecting characters and songs that he cherishes. He also speaks a little bit of Japanese, so feel ...